preserved

  1. A

    Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

    Heart failure with preserved ejection fraction is increasing in prevalence and is associated with a high symptom burden and functional impairment, especially in persons with obesity. No therapies have been approved to target obesity-related heart failure with preserved ejection fraction. The...
    • AASraw-Cherry
    • Thread
    • analysis body change compared conclusion ejection failure fraction greater group heart hfpef limitations obesity patients physical placebo points preserved reported semaglutide significant symptoms treatment weight
    • Replies: 0
    • Forum: AAS RAW FORUM
Back
Top